Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study

Purpose: The study aims to retrospectively investigate the efficacy and safety of sorafenib combined with transarterial chemoembolization (TACE) (TACE+Sor) vs. TACE combined with sorafenib plus immune checkpoint inhibitors (TACE+Sor+ICIs) in treating intermediate and advanced TACE-refractory hepatoc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Mol Biosci
Glavni autori: Zheng, Liyun, Fang, Shiji, Wu, Fazong, Chen, Weiqian, Chen, Minjiang, Weng, Qiaoyou, Wu, Xulu, Song, Jingjing, Zhao, Zhongwei, Ji, Jiansong
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Molecular Biosciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843459/
https://ncbi.nlm.nih.gov/pubmed/33521054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.609322
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items